Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

H3 receptor blockade with GT-2227 increases wakefulness without subsequent hypersomnolence

July 17, 1998

BIBN-99 improves cognition independent of effects on sleep

July 17, 1998

Cambridge NeuroScience and Boehringer Ingelheim end Cerestat collaboration

July 17, 1998

Venlafaxine relieves anxiety; more cost-effective than other antidepressants

July 16, 1998

Lilly team claims metabotropic glutamate receptor antagonists

July 16, 1998

CNS compounds from ADIR that selectively bind to D4 receptors

July 16, 1998

Phase II clinical trial begins for fibromyalgia treatment

July 16, 1998

Risperidone: satellite symposia discuss impact on cognition and behavior

July 16, 1998

Pfizer reports pharmacokinetics of a novel anxiolytic agent - CP-93393

July 16, 1998

M-100907 improves positive and negative symptoms and is well tolerated in schizophrenics

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...